XML 51 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
Collaboration arrangements and concentration of credit risk (Tables)
 3 Months Ended
Mar. 31, 2017
Collaboration arrangements and concentration of credit risk  
Schedule of collaboration and license revenue

 

 

Three months ended March 31,

 

 

 

2017

 

2016

 

 

 

in thousands

 

Bristol Myers Squibb

 

$
1,507

 

$
2,628

 

Chiesi Farmaceutici S.p.A

 
1,814

 
1,667

 

 

 

 

 

 

 

Total

 

$
3,321

 

$
4,295

 

 

 

 

 

 

 

 

 

 

Schedule of amounts owed in relation to collaboration

 

 

 

March 31,

 

December 31,

 

 

 

2017

 

2016

 

 

 

in thousands

 

Bristol Myers Squibb

 

$
517

 

$
5,500

 

Chiesi Farmaceutici S.p.A

 
1,233

 
3,680

 

 

 

 

 

 

 

Total

 

$
1,750

 

$
9,180